Display options
Share it on

HIV Med. 2021 Apr;22(4):294-306. doi: 10.1111/hiv.13017. Epub 2020 Nov 17.

Association of body mass index with immune recovery, virological failure and cardiovascular disease risk among people living with HIV.

HIV medicine

W M Han, A Jiamsakul, J Jantarapakde, E Yunihastuti, J Y Choi, R Ditangco, R Chaiwarith, L P Sun, S Khusuwan, T P Merati, C D Do, I Azwa, M-P Lee, K Van Nguyen, Y-J Chan, S Kiertiburanakul, O T Ng, J Tanuma, S Pujari, F Zhang, Y M Gani, S Sangle, J Ross, N Kumarasamy,

Affiliations

  1. The Kirby Institute, UNSW, Sydney, NSW, Australia.
  2. HIV-NAT, Thai Red Cross AIDS Research Centre, Bangkok, Thailand.
  3. Faculty of Medicine, Universitas Indonesia - Dr Cipto Mangunkusumo General Hospital, Jakarta, Indonesia.
  4. Division of Infectious Diseases, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.
  5. Research Institute for Tropical Medicine, Muntinlupa City, Philippines.
  6. Research Institute for Health Sciences, Chiang Mai, Thailand.
  7. National Center for HIV/AIDS, Dermatology & STDs, Phnom Penh, Cambodia.
  8. Chiangrai Prachanukroh Hospital, Chiang Rai, Thailand.
  9. Faculty of Medicine, Udayana University & Sanglah Hospital, Bali, Indonesia.
  10. Bach Mai Hospital, Hanoi, Vietnam.
  11. University Malaya Medical Centre, Kuala Lumpur, Malaysia.
  12. Queen Elizabeth Hospital, Hong Kong SAR, India.
  13. National Hospital for Tropical Diseases, Hanoi, Vietnam.
  14. Taipei Veterans General Hospital, Taipei, Taiwan.
  15. Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
  16. Tan Tock Seng Hospital, Singapore, Singapore.
  17. National Center for Global Health and Medicine, Tokyo, Japan.
  18. Institute of Infectious Diseases, Pune, India.
  19. Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  20. Hospital Sungai Buloh, Sungai Buloh, Malaysia.
  21. BJ Government Medical College and Sassoon General Hospital, Pune, India.
  22. TREAT Asia, amfAR - The Foundation for AIDS Research, Bangkok, Thailand.
  23. Chennai Antiviral Research and Treatment Clinical Research Site (CART CRS), VHS-Infectious Diseases Medical Centre, VHS, Chennai, India.

PMID: 33200864 PMCID: PMC8428815 DOI: 10.1111/hiv.13017

Abstract

OBJECTIVES: We conducted a longitudinal cohort analysis to evaluate the association of pre-treatment body mass index (BMI) with CD4 recovery, virological failure (VF) and cardiovascular risk disease (CVD) markers among people living with HIV (PLHIV).

METHODS: Participants who were enrolled between January 2003 and March 2019 in a regional Asia HIV cohort with weight and height measurements prior to antiretroviral therapy (ART) initiation were included. Factors associated with mean CD4 increase were analysed using repeated-measures linear regression. Time to first VF after 6 months on ART and time to first development of CVD risk markers were analysed using Cox regression models. Sensitivity analyses were done adjusting for Asian BMI thresholds.

RESULTS: Of 4993 PLHIV (66% male), 62% had pre-treatment BMI in the normal range (18.5-25.0 kg/m

CONCLUSIONS: High pre-treatment BMI was associated with better immune reconstitution and CVD risk factor development in an Asian PLHIV cohort.

© 2020 British HIV Association.

Keywords: HIV; body mass index; cardiovascular risks; immune recovery; virological response

References

  1. Int J Obes (Lond). 2007 Aug;31(8):1232-9 - PubMed
  2. Lancet HIV. 2017 Aug;4(8):e349-e356 - PubMed
  3. Curr HIV/AIDS Rep. 2018 Feb;15(1):60-71 - PubMed
  4. J Acquir Immune Defic Syndr. 2016 Oct 1;73(2):228-36 - PubMed
  5. PLoS One. 2019 Feb 5;14(2):e0211344 - PubMed
  6. Med Princ Pract. 2013;22(1):54-8 - PubMed
  7. Antivir Ther. 2016;21(6):517-527 - PubMed
  8. AIDS. 2015 Mar 27;29(6):667-74 - PubMed
  9. J Int AIDS Soc. 2019 Jan;22(1):e25236 - PubMed
  10. AIDS. 2017 Jun 1;31 Suppl 2:S121-S128 - PubMed
  11. J Infect Dis. 2019 Jul 2;220(3):420-431 - PubMed
  12. Br J Nutr. 2009 Aug;102(4):632-41 - PubMed
  13. Arthritis Res Ther. 2006;8(5):217 - PubMed
  14. J Acquir Immune Defic Syndr. 2018 Feb 1;77(2):e14-e21 - PubMed
  15. HIV Med. 2016 Apr;17(4):255-68 - PubMed
  16. J Acquir Immune Defic Syndr. 2016 Oct 1;73(2):197-204 - PubMed
  17. Exp Diabetes Res. 2012;2012:103063 - PubMed
  18. J Acquir Immune Defic Syndr. 2018 Aug 15;78(5):579-588 - PubMed
  19. Br J Nutr. 2016 Jun;115(12):2114-21 - PubMed
  20. Am J Infect Dis. 2006;2(3):141-152 - PubMed
  21. BMC Infect Dis. 2019 May 2;19(1):373 - PubMed
  22. J Infect Dis. 2013 Oct 15;208(8):1194-201 - PubMed
  23. J Acquir Immune Defic Syndr. 2010 Apr 1;53(4):507-13 - PubMed
  24. AIDS Res Hum Retroviruses. 2016 Aug;32(8):772-81 - PubMed
  25. HIV Clin Trials. 2011 Jul-Aug;12(4):222-7 - PubMed
  26. HIV Med. 2015 Jan;16(1):67-72 - PubMed
  27. Nat Rev Immunol. 2006 Oct;6(10):772-83 - PubMed
  28. J Endocrinol. 2014 Jan 08;220(2):T47-59 - PubMed
  29. AIDS. 2010 Apr 24;24(7):1069-72 - PubMed
  30. Metabolism. 2009 Aug;58(8):1200-7 - PubMed
  31. HIV Med. 2015 Oct;16(9):572-7 - PubMed
  32. Nature. 1998 Aug 27;394(6696):897-901 - PubMed
  33. Metabolism. 1997 Mar;46(3):303-5 - PubMed

Publication Types

Grant support